TLDR
- Moderna stock rose over 8% in premarket trading Monday after a U.S. national tested positive for the Andes hantavirus strain
- Moderna confirmed it is conducting “early-stage and ongoing” preclinical research on hantavirus in collaboration with USAMRIID
- Inovio jumped 13%, Novavax rose 3%, and Emergent Biosolutions gained 4% in early trading
- WHO has assessed the public health risk as low — eight cases reported, three deaths, five confirmed as hantavirus
- Evercore ISI analysts said they see “no meaningful revenue opportunity” for Moderna from the outbreak
The rally in Moderna stock has more to do with investor sentiment than science right now.
Moderna (MRNA) jumped 8.5% to around $58.99 in Monday premarket trading, continuing a run that started Friday when the stock climbed 12%. From its 52-week closing low of $22.26 in November 2025, the stock has now risen roughly 161%.
The catalyst: a U.S. national on board the MV Hondius cruise ship tested positive for the Andes strain of hantavirus, a rare rodent-borne respiratory virus that is the only hantavirus strain capable of human-to-human transmission.
The Department of Health and Human Services confirmed that all 17 American citizens from the ship are being repatriated to the U.S. Two passengers are traveling in biocontainment units on the repatriation flight — one tested mildly positive, another is showing mild symptoms.
Moderna acknowledged its hantavirus work in a statement to CNBC. The company said it has conducted preclinical research on hantaviruses with USAMRIID, calling the work “early-stage and ongoing” and part of a “broader responsibility to develop countermeasures against emerging infectious diseases.”
That’s enough for markets to run with it — at least for now.
Analysts Push Back on the Rally
Evercore ISI was direct in a note published May 7. Analysts said Moderna “tends to trade on outbreak headlines well beyond the underlying commercial implications,” and that they see “no meaningful revenue opportunity” from hantavirus.
“Hantavirus is a low-incidence, structurally small market,” Evercore wrote. “We view any potential outsized moves as sentiment-driven, not fundamental.”
The broader biotech space moved too. Inovio Pharmaceuticals (INO) jumped 13% in early trading. Novavax (NVAX) gained around 3%, and Emergent Biosolutions (EBS) was up roughly 4%.
The WHO flagged the outbreak on May 2 after passengers on the Dutch-flagged expedition ship contracted the virus while sailing the Atlantic. WHO Director General Tedros Adhanom Ghebreyesus confirmed eight cases total — five confirmed as hantavirus — and three deaths. The WHO assessed the public health risk as low.
What We Know About the Outbreak
President Trump addressed the situation Thursday, saying the cruise ship outbreak is “very much under control” and that a full report was expected to follow.
The MV Hondius has since docked in Tenerife in Spain’s Canary Islands. Passengers and crew have disembarked under strict health protocols, with coordinated testing, isolation, and repatriation efforts underway across multiple countries.
Health authorities have been consistent: human-to-human transmission of the Andes strain is rare, and the risk of a wider outbreak remains low.
Moderna is now on track for its highest close since October 2024 if premarket gains hold into the session.
🚨 Our MAY Stock Picks Are Live!
A new month means new opportunities. Our analysts have just released their top stock picks for May, highlighting companies with strong momentum that rank highly on our KO Score algorithm. We’re also now sharing trade ideas for both long-term and short-term investors, giving you more ways to spot potential opportunities in the market.
Sign up to Knockout Stocks today and get 50% off to unlock the full list and see which stocks made the cut.
Use coupon code Special50 for your exclusive discount!
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
